Inhibition of tumor angiogenesis during cisplatin chemotherapy for bladder cancer improves treatment outcome. [electronic resource]
Producer: 20051005Description: 395-9 p. digitalISSN:- 1527-9995
- Angiogenesis Inhibitors -- administration & dosage
- Animals
- Antibiotics, Antineoplastic -- administration & dosage
- Antineoplastic Agents, Alkylating -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Apoptosis
- Carcinoma, Transitional Cell -- blood supply
- Cisplatin -- administration & dosage
- Combined Modality Therapy
- Cyclohexanes
- Drug Screening Assays, Antitumor
- Drug Synergism
- Injections, Intraperitoneal
- Male
- Neovascularization, Pathologic -- drug therapy
- O-(Chloroacetylcarbamoyl)fumagillol
- Random Allocation
- Rats
- Sesquiterpenes -- administration & dosage
- Urinary Bladder Neoplasms -- blood supply
No physical items for this record
Publication Type: Comparative Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.